Many potential participants are put off joining a clinical trial for fear of the potential side effects or lack of benefit they may experience from the treatment under investigation, especially if there is an alternative treatment available that is part of the normal standard of care. In order to participate in a trial many potential participants in a clinical trial must consider the time and cost impact of participation such as transportation, time away from work or family obligations, child care, and other considerations. The problem is worse in regions and cultures with low literacy levels, according to a 2020 article published in Perspectives in Clinical Research. ![]() ![]() Potential participants usually don’t know about clinical trials being conducted for their health conditions unless their physician personally brings it to their attention. The industry is rightly seeking ways to overcome enrollment blocks.Įach study is different, of course, but some of the most common obstacles to timely enrollment include: In some cases these delays turn into terminations, causing frustration as well as financial losses. In fact, 80 percent of global trials do not enroll on time. While it may sometimes seem that such research proceeds at a dizzying pace – consider the development of COVID-19 vaccines, for example – the unfortunate reality is that researchers often encounter lengthy delivery delays, primarily linked to study enrollment. ![]() Life science companies are dependent on clinical research to improve our knowledge of life-altering diseases, develop better diagnostic methods and design new treatments or medical devices to ensure better patient care.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |